RemeGen Co., Ltd.
REGMF · OTC
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/31/2024 | |
|---|---|---|---|---|
| Market Cap | $2,842,930 | $19,239,372 | $6,013,445 | $5,870,739 |
| - Cash | $150,261 | $1,283,086 | $721,718 | $759,530 |
| + Debt | $306,469 | $2,674,542 | $2,729,040 | $2,670,511 |
| Enterprise Value | $2,999,139 | $20,630,828 | $8,020,766 | $7,781,720 |
| Revenue | $86,661 | $571,985 | $525,969 | $507,987 |
| % Growth | -84.8% | 8.7% | 3.5% | – |
| Gross Profit | $73,247 | $484,996 | $437,938 | $406,013 |
| % Margin | 84.5% | 84.8% | 83.3% | 79.9% |
| EBITDA | -$12,130 | -$105,333 | -$169,176 | -$328,629 |
| % Margin | -14% | -18.4% | -32.2% | -64.7% |
| Net Income | -$14,194 | -$195,424 | -$254,144 | -$396,934 |
| % Margin | -16.4% | -34.2% | -48.3% | -78.1% |
| EPS Diluted | -0.025 | -0.37 | -0.46 | -0.74 |
| % Growth | 93.2% | 19.6% | 37.8% | – |
| Operating Cash Flow | $64,632 | -$57,224 | -$188,315 | -$279,200 |
| Capital Expenditures | -$7,882 | -$84,914 | -$35,639 | -$85,330 |
| Free Cash Flow | $56,750 | -$142,138 | -$223,954 | -$364,531 |